Amgen hires senior VP, general counsel and secretary
May 20, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, jonathan graham
Amgen has appointed Jonathan Graham as its senior vice president, general counsel and secretary who will take to his post in July. …
Merck KGaA’s sales climb but key drugs fall
May 19, 2015Sales and Marketing Erbitux, Merck, Merck KGaA, Q1, Rebif
Merck KGaA encountered an uneven start to 2015, with robust sales in the first quarter offset by declines in key …
Endo lands a big fish with $8 billion Par Pharma deal
May 19, 2015Sales and Marketing Endo, Valeant, par pharma
Endo is switching strategies from attempting to buy specialist pharma firms, to generics, having announced a huge $8 billion deal …
AstraZeneca building $285m biologics plant in Sweden
May 19, 2015Manufacturing and Production, Sales and Marketing AstraZeneca, Sweden, Södertälje, brett wells
AstraZeneca is spending around $285 million on a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The …
Pfizer head joins UK biotech Calchan
May 19, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, calhan, zahid ali
UK-based biotech Calchan has looked to Pfizer for appointing a new chief scientific officer in Zahid Ali. Ali has almost …
Cameron restates £8 billion NHS funding plans
May 18, 2015Sales and Marketing BMA, Cameron, NHS, UK
UK prime minister David Cameron has committed to extra funding for the NHS in his first major speech following the …
FDA issues more diabetes drug warnings
May 18, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Boehringer, J&J, JJ, lilly
The FDA has warned that a class of type 2 diabetes drugs manufactured by several big pharma firms could cause …
Boehringer widens IPF drug’s reach
May 18, 2015Sales and Marketing Boehringer, Esbriet, ats, brett wells, nintedanib, ofev
Boehringer Ingelheim has highlighted new data for its idiopathic pulmonary fibrosis (IPF) treatment Ofev in a Phase II study on …
Takeda appoints new business unit director
May 18, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, craig adkins
Takeda UK has appointed Craig Adkins as the new director of its its inflammatory bowel disease (IBD) business unit. Adkins …
The EU Falsified Medicines Directive: what does pharma need patients to know?
May 18, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing eu falsified, waarde
Recent legislation assumes that visual information can have direct effects on people’s behaviour. It starts from the assumption that a …
Merck KGaA reveals ASCO plans
May 15, 2015Sales and Marketing ASCO, Merck, Merck KGaA, Merck Serono, avelumab
Merck KGaA is the latest company to announce its slate for this year’s ASCO conference, and like other firms it …
Teva lifted by positive migraine drug results
May 15, 2015Sales and Marketing TEV-48125, Teva, headaches, migraine
Patients who take either dose of Teva’s investigational treatment for chronic migraine improve more than those taking a placebo according …
London hospital pilots Apple watch app in chemotherapy
May 15, 2015Medical Communications, Sales and Marketing Apple, King’s College Hospital, brett wells, chemo, medopad, watch, wearables
King’s College Hospital in London is piloting a scheme whereby cancer patients moving through chemotherapy treatments are given an Apple …
Virgo Health Education announces new senior team
May 15, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo Health Education
Virgo Health Education has appointed a new head of medical education and announced a number of senior team promotions. Katherine …
AstraZeneca eyes success in immuno-oncology combinations
May 14, 2015Sales and Marketing ASCO, AZ, AstraZeneca, CTLA-4, MEDI4736
An investigational immuno-oncology drug combination from AstraZeneca has shown promise in its most recent trial, although concerns over its side …
Survey reveals pharma’s most reputable companies
May 14, 2015Medical Communications, Sales and Marketing Novartis, nayer, reputation
Bayer has held on to the top spot in a global survey of how much the general public trusts and …
Roche lung cancer treatments perform
May 14, 2015Sales and Marketing MPDL3280A, Roche, alectinib, immunotherapy
Roche has revealed promising trial data from two lung cancer treatments with one improving survival and the other shrinking tumours. …
Takeda hits major snags with Contrave and Alisertib
May 14, 2015Sales and Marketing Contrave, Takeda, alisertib, obesity, orexigen
Takeda is threatening to end its partnership with Orexigen to market the obesity drug Contrave, as allegations around its heart …
OrthoAccel Technologies appoints new board member
May 14, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OrthoAccel Technologies, len hedge
US-based medical device firm OrthoAccel Technologies has announced that Len Hedge has joined its board of directors. Hedge currently serves on the …
UK doctors urged to curb overtreatment
May 13, 2015Sales and Marketing Academy of Medical Royal Colleges, BMJ, NHS, uk doctors
The UK’s body of medical colleges has launched a new campaign to warn of the dangers of over-treating patients with …
Latest content
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
